News

According to Solvay, this means that the formal processing and review period both begin. This event has triggered a milestone payment of $25 million from Wyeth, Solvay's co-development

The agreement will include including Epix's novel 5-HT4 partial agonist program, PRX-03140, in early-stage clinical development for the treatment of Alzheimer's disease. The alliance will be conducted through

In addition, the early analysis indicates a trend toward improvement in overall survival in the Avastin plus interferon arm. “We are pleased with the results demonstrating improvement in

Velcade is an FDA approved treatment for relapsed or refractory multiple myeloma. The study results demonstrate that patients who received a combination of Doxil and Velcade had 45%

The acquisition would strengthen Johnson & Johnson's position as the world's largest supplier of consumer health-care and over-the-counter medicines. The Commission said the acquisition did raise some concerns

This breakthrough data showed that in myelodysplastic syndrome (MDS) patients with chromosome 5q deletion treatment, Revlimid can provide long-term durable results and help them to remain transfusion free.

The companies intend to develop, and distribute tenofovir to women in resource-limited countries to prevent infection with HIV, the virus that causes AIDS. “It is through public-private partnerships

The trial, which is taking place in Sweden, will assess the efficacy and safety of topical interferon alpha-2b compared with placebo over an examination period of four months

The study met its primary endpoint by demonstrating superior progression free survival in patients with B-cell chronic lymphocytic leukemia (B-CLL) treated with Campath versus chlorambucil. Campath reduced the